Exhibit 107
Calculation of Filing Fee Tables
Form S-1 | ||
(Form Type) |
CHEMOMAB THERAPEUTICS LTD. | ||
(Exact Name of Registrant as Specified in its Charter) |
Table 1: Newly Registered and Carry Forward Securities
Security Type | Security Class Title | Fee Calculation or Carry Forward Rule | Maximum Aggregate Offering Price(1)(2) | Fee Rate | Amount of Registration Fee | ||||||||||||
Newly Registered Securities | |||||||||||||||||
Fees to be Paid | Equity | American Depositary Shares (2) | (1) | $ | 15,000,000.00 | $ | .0001102 | $ | 1,653.00 | ||||||||
Fees to be Paid | Other | Warrants to Purchase American Depositary Shares (2) | (3) | ||||||||||||||
Fees to be Paid | Equity | American Depositary Shares issuable upon exercise of warrants (2) | (1) | $ | 15,000,000.00 | $ | .0001102 | $ | 1,653.00 | ||||||||
Total Offering Amounts | $ | 30,000,000.00 | $ | 3,306.00 | |||||||||||||
Total Fees Previously Paid | $ | 2,534.60 | |||||||||||||||
Total Fee Offsets | - | ||||||||||||||||
Net Fee Due | $ | 771.40 |
(1) | Estimated solely for the purpose of computing the amount of the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended. | |
(2) | Each ADS represents twenty (20) ordinary shares of the registrant. ADSs issuable upon deposit of the ordinary shares registered hereby have been registered pursuant to a separate registration statement on Form F-6 (File No. 333-229522). | |
(3) | Calculated in accordance with Rule 457(g) under the Securities Act, because the ADSs of the registrant underlying the warrants are registered hereby. |